Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke (CLOTBUST-ER)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Cerevast Therapeutics, Inc.
Sponsor:
Information provided by (Responsible Party):
Cerevast Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01098981
First received: April 2, 2010
Last updated: September 5, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)